Miranda et al.21 demonstrated a lower proliferative rate, and a lower expression of RUNX2 and Osterix, transcription factors driving osteoblast differentiation, in osteogenic lineage cells isolated from type 2 diabetic patients who had osteoporotic hip fractures. Here, RUNX2 is linked to type 2 diabetes mellitus.